An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone who’s had three bariatric (weight-loss) surgeries says they started taking Ozempic earlier this year, worked with a nutritionist, lost a lot at first, and then stopped losing weight — they’ve been stuck at the same weight for about five months despite continuing treatment. They’re asking for insight and support because the plateau is worrying after an initially strong response. Ozempic is the brand name for a drug whose active ingredient is semaglutide. That chemical is a man-made version of a gut hormone your body makes naturally after you eat. It helps people feel less hungry, makes meals feel more satisfying, and can slow how fast the stomach empties so you don’t feel hungry again as soon. Doctors use it to help with long-term weight loss and to manage blood sugar in diabetes, usually as a weekly injection. What this person reports isn’t a controlled study — it’s a single patient’s experience. Clinical trials of semaglutide show many people lose substantial weight at first, but the amount and timing vary a lot between individuals. It’s also common in both research settings and real life for weight loss to slow down or stop after an initial phase. That plateau can be due to the body adapting, changes in metabolism, small increases in calorie intake that creep in when you feel better, or other health and behavioral factors. The post doesn’t include details like dose changes, other medications, exact weight history, or lab tests, so we can’t say why their weight specifically stalled. This matters because plateaus are frustrating and can make people doubt their treatment or fall back into old habits. For someone who’s had multiple bariatric surgeries, the physiology and nutrition needs are different than for people who haven’t had surgery. The practical takeaways are: it’s common to hit a plateau; it’s worth reviewing your plan with your care team (nutritionist, surgeon or bariatrician, and the prescriber) to check whether your dose, eating patterns, activity, sleep, stress, or other meds might be playing a role; and sometimes small, sustainable adjustments — not drastic changes — help restart progress. There are important caveats. Semaglutide isn’t a magic bullet; it works best as part of a medical and behavioral program. Side effects can include nausea, digestive upset, and in rare cases more serious issues; people with certain medical histories need extra caution. Also, long-term use and what happens if someone stops the drug are areas where experiences differ. Because this is a personal report, it can’t tell you how typical the experience is or what the right next step is for any individual. If someone is plateauing and worried, the safest move is to consult the prescribing clinician rather than trying unproven or risky fixes. Bottom line: hitting a weight-loss plateau on Ozempic is a common, frustrating problem that’s worth re-evaluating with your medical team rather than abandoning treatment or assuming it no longer works.
Source: r/Semaglutide